Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New adenosine A2A and A2B receptors disclosed by Merck KGaA

May 14, 2020

Nurix Therapeutics patents Bruton tyrosine kinase-degrading compounds

May 14, 2020

Insilico Medicine Hong Kong discovers DDR1 inhibitors

May 14, 2020

New androgen receptor antagonists described by ESSA Pharma

May 14, 2020

TBR-760 results in complete arrested tumor growth in mouse model of NFPA

May 14, 2020

Arrowhead opens enrollment in phase Ib study of ARO-HIF2 in advanced clear cell renal cell carcinoma

May 13, 2020

Myelopro Diagnostics & Research presents new compounds binding to calreticulin

May 13, 2020

NTRK1 inhibitors discovered at Medshine Discovery

May 13, 2020

AQX-435 shows promising activity in models of B-cell malignancies

May 13, 2020

Tukysa approved in Switzerland for metastatic HER2-positive breast cancer

May 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...